Evidence map›Paper›PMID 17943181›Full record

ArticleThe Journal of investigative dermatology2008

Multiple PKCdelta tyrosine residues are required for PKCdelta-dependent activation of involucrin expression--a key role of PKCdelta-Y311.

Ling Zhu, Chaya Brodie, Sivaprakasam Balasubramanian, Richard L Eckert

Abstract read
In one paragraph

Article in The Journal of investigative dermatology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ling ZhuDepartment of Physiology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Chaya Brodie
Sivaprakasam Balasubramanian
Richard L Eckert
Case Western Reserve University · USHenry Ford Hospital · US

Funding

UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANTP30CA134274 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI FEYRUZ VIRGILIA RASSOOL · 2008 to 2026
$51.0M
Vitamin D endocrine system and Protection Against Skin TumorlgenesisP30AR039750 · NIAMS · CASE WESTERN RESERVE UNIVERSITY · PI COOPER, KEVIN D · 1988 to 2015
$9.1M
MAP KINASES REGULATE INVOLUCRIN GENE EXPRESSIONR01AR046494 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI ECKERT, RICHARD L. · 2000 to 2010
$1.9M
Regulation of Glioma Cell Apoptosis in PKCDeltaR01CA109196 · NCI · HENRY FORD HEALTH SYSTEM · PI BRODIE, CHAYA · 2005 to 2008
$991k
NCI NIH HHS P30 CA134274NCI NIH HHS R01 CA109196NCI NIH HHS R01CA109196NIAMS NIH HHS AR39750NIAMS NIH HHS P30 AR039750NIAMS NIH HHS R01 AR046494NIAMS NIH HHS R01AR046494
6 · The paper itself

Abstract

Protein kinase C-delta (PKCdelta) is a key regulator of human involucrin (hINV) gene expression and is regulated by tyrosine phosphorylation. However, a comprehensive analysis of the requirement for individual PKCdelta tyrosine residues is lacking. We show that multiple tyrosine residues influence the ability of PKCdelta to increase hINV gene expression. Mutation of individual PKCdelta tyrosine residues 52, 64, 155, 187, or 565 does not reduce the ability of PKCdelta to increase hINV promoter activity; however, simultaneous mutation of these five tyrosines markedly reduces activity. Moreover, restoration of any one of these residues results in nearly full activity restoration. It is significant that phosphorylation of PKCdelta-Y(311) is reduced in the five-tyrosine mutant and that mutation of Y(311) results in reduced PKCdelta activity comparable to that observed in the five-tyrosine mutant. Restoration of any one of the tyrosine residues in the five-tyrosine mutant restores Y(311) phosphorylation and biological activity. In addition, reduced phosphorylation of endogenous PKCdelta-Y(311) is associated with reduced biological activity. These findings indicate that PKCdelta activity requires Y(311) and a second tyrosine residue; however, any one of the several tyrosine residues can serve in the secondary role.

Indexed as

Gene Expression RegulationAmino Acid SubstitutionHumansKeratinocytesMutationPhosphorylationPromoter Regions, GeneticProtein Kinase C-deltaProtein PrecursorsProtein Structure, TertiaryTyrosineinvolucrinProtein Kinase C-deltaProtein PrecursorsTyrosine

Identifiers

PMID17943181
PMCPMC3124846
OpenAlexW2068348271

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.